Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6)

18 Dec 2020

Abstract excerpt

Low-density lipoprotein receptor-related protein 6 (LRP6) is an important therapeutic target for diseases such as osteoporosis, Alzheimer, cancer, and neurodegenerative disease. Computational methods such as ligand-based and structure-based virtual screening have been introduced as an extremely efficient and accurate tool for finding new drug targets and candidates. In this study, we aimed to screen the National...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Lipoproteins and Cardiovascular Health
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33351722
DOI: 10.1080/07391102.2020.1857843

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6)PMID 33351722Read ↗

A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic SimulationsSemantic proximity Read ↗

Virtual screening of zinc compounds similar to NSAIDS with better pharmacodynamic and pharmacokinetic profilesSemantic proximity Read ↗

Designing peptide inhibitors targeting LRP6 co-receptor to restrict its association to DKK1; an Alzheimer’s disease therapeutic strategySemantic proximity Read ↗

Unveiling novel insights into human IL-6 - IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis.Semantic proximity Read ↗

Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics StudiesSemantic proximity Read ↗

In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database.Semantic proximity Read ↗

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 ProteinSemantic proximity Read ↗

Network Pharmacology Reveals the Potential of Dolastatin 16 as Diabetic Wound Healing AgentSemantic proximity Read ↗

Computational Insights into the Molecular Mechanism of the High Immunomodulatory Activity of LZ-8 Protein Isolated from the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes).Semantic proximity Read ↗

Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approachesSemantic proximity Read ↗

Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiencySemantic proximity Read ↗

AMPA GluA2 subunit competitive inhibitors for PICK1 PDZ domain: Pharmacophore-based virtual screening, molecular docking, molecular dynamic simulation, and ADME studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.